NCT02631044 2024-06-27Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)Juno Therapeutics, a Subsidiary of CelgenePhase 1 Completed387 enrolled 2 FDA